Cervical Fixation Surgery Cervical Collar for Management of Hirayama Disease: A Randomized Study

Sponsor
All India Institute of Medical Sciences, New Delhi (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05959980
Collaborator
(none)
80
1
2
38
2.1

Study Details

Study Description

Brief Summary

The goal of this clinical trial] is to compare cervical collar versus neck stabilization surgery in diagnosed patients of Hirayama disease who have been reporting worsening of problems in the past six months. The main question[s] it aims to answer are:

• Is cervical stabilization surgery (Posterior cervical fixation) superior to conservative management in the form of cervical collar placement in patients with progressive Hirayama disease, observed at six months after intervention

Participants will have equal chance to:
  • Undergo cervical fixation surgery

  • Cervical collar management The investigators will study and compare the efficacy of both treatments upto six months after intervention

Condition or Disease Intervention/Treatment Phase
  • Procedure: Posterior cervical fixation surgery
N/A

Detailed Description

  1. Study design:

Prospective randomized open blinded endpoint (PROBE), phase III study

  1. Inclusion criteria:
All the following:
  1. Age ≥ 18 years

  2. Patients with Hirayama disease as per the following criteria (All of the following) (16):

  3. Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion)

  4. Progressive course, or initial progression followed by stationary course; and

  5. No evidence of a compressive lesion of the spinal cord.

  6. Disease duration of ≤4 years

  7. Progression of clinical symptoms in the past six-months c. Exclusion criteria:

Any of the following:
  1. Refusal to consent for randomization 2) Not willing to come for three- and six-months follow-up e. Procedures at baseline:
  1. Clinical, electrophysiology and autonomic function assessments:

After the clinical diagnosis by inclusion criteria, the patients will undergo a detailed clinical examination (as per the case record form (CRF), which includes power, autonomic features, grip strength), and the objective assessment of the electrophysiological parameters

  1. Radiological assessment:

All patients will undergo MR imaging on a 1.5 T MR scanner (Optima 450w, General Electric, Milwaukee, USA), using an 8-channel cervical-thoracic-lumbar array spine coil. The imaging will include axial and sagittal T2-WIs and post-gadolinium T1+C in flexion, neutral and extension positions. In addition, DTI protocol will include sagittal and axial acquisition of cervical cord in neutral position. MR-DTI data will process on a dedicated workstation (Advantage Windows workstation, GE Healthcare, WI, USA) using commercially available software (Functool 14.3.01, GE HealthCare, WI, USA). After co-registration of raw images to correct the motion and distortion artefacts, the ADC and FA images will be generated. The mean, minimum and maximum values of FA and ADC will be recorded from region of maximum cord compression/ T2-hyperintensity.

The investogators will get a cervical spine radiograph at the time of discharge and at 6 months.

  1. Surgical procedure:

The patients who are randomized to undergo posterior cervical fixation will be admitted in Neurosciences Centre, All India Institute of Medical Sciences, New Delhi. These patients will undergo routine preoperative work up, including routine blood investigations and a detailed preanesthetic checkup (PAC). These patients will undergo posterior cervical fixation in the form of cervical lateral mass screw fixation in extension without decompression under general anesthesia.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Posterior Cervical Fixation Versus Long-term Cervical Collar for Management of Hirayama Disease: Prospective Randomized Open Blinded Endpoint (PROBE), Phase III Study
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Surgical arm

Will undergo posterior cervical fixation surgery within 4 weeks of randomization

Procedure: Posterior cervical fixation surgery
These patients will undergo posterior cervical fixation in the form of cervical lateral mass screw fixation in extension without decompression under general anesthesia.

No Intervention: Cervical collar arm

Will be given cervical collar for regular use

Outcome Measures

Primary Outcome Measures

  1. Odom's criteria score at six months [Six months after intervention]

Secondary Outcome Measures

  1. Odom's criteria score at three months [Three months after intervention]

  2. interval change in DTI metrics of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) of cervical cord [at six-months post-intervention]

  3. Electrophysiological and grip strength [6 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All the following:
  1. Age ≥ 18 years

  2. Patients with Hirayama disease as per the following criteria (All of the following) (16):

  3. Clinical evidence of wasting and weakness confined to one limb (EMG evidence of denervation in the opposite limb will not be a reason for exclusion)

  4. Progressive course, or initial progression followed by stationary course; and

  5. No evidence of a compressive lesion of the spinal cord.

  6. Disease duration of ≤4 years

  7. Progression of clinical symptoms in the past six-months

Exclusion Criteria:
  • Any of the following:
  1. Refusal to consent for randomization

  2. Not willing to come for three- and six-months follow-up

Contacts and Locations

Locations

Site City State Country Postal Code
1 Deepti Vibha New Delhi Delhi India 110029

Sponsors and Collaborators

  • All India Institute of Medical Sciences, New Delhi

Investigators

  • Principal Investigator: Deepti Vibha, AIIMS, New Delhi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deepti Vibha, Professor, Neurology, All India Institute of Medical Sciences, New Delhi
ClinicalTrials.gov Identifier:
NCT05959980
Other Study ID Numbers:
  • AC-60
First Posted:
Jul 25, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Deepti Vibha, Professor, Neurology, All India Institute of Medical Sciences, New Delhi
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023